ERJ open research · 2026
Differentiating benign and malignant solitary pulmonary nodules through exhaled breath analysis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zwijsen Kathleen, Wener Reinier R L, Heirwegh Ellen, van Meerbeeck Jan P, Schillebeeckx Eline, Raskin Jo, Marcq Elly, Van Schil Paul E, Snoeckx Annemiek, Janssens Annelies, Lamote Kevin
Аннотация
BACKGROUND: Lung cancer remains the leading cause of cancer-related deaths worldwide, with early detection significantly improving survival. Lung nodules are a common finding, both as incidental solitary pulmonary nodules (SPNs) and in lung cancer screening programmes. Accurately distinguishing benign from malignant nodules, particularly small ones, remains challenging. Determining which nodules require further investigation is crucial for optimising early lung cancer detection and reducing unnecessary procedures. Therefore, volatile organic compounds (VOCs) in exhaled breath are analysed using multicapillary column/ion mobility spectrometry (MCC/IMS) to differentiate malignant from benign SPNs, serving as potential biomarkers for lung cancer.
METHODS: A total of 65 patients with an incidental, solitary pulmonary malignant (n=41) or benign (n=24) nodule were prospectively included. Two models were developed: a pre-computed tomography (CT) scan situation for triaging high-risk individuals prior to imaging, and a post-CT scan situation to assist with nodule management and follow-up.
RESULTS: Four VOCs (VOC37, VOC46, VOC58 and VOC128) were identified as key compounds, showing strong diagnostic performance (area under the curve 0.900 for pre-CT scan and 0.897 for post-CT scan).
CONCLUSIONS: Our findings suggest that breath analysis could improve nodule management by refining patient selection for CT screening and reducing unnecessary invasive procedures or follow-up scans. Further validation through larger multicentre studies is needed to confirm these results.
METHODS: A total of 65 patients with an incidental, solitary pulmonary malignant (n=41) or benign (n=24) nodule were prospectively included. Two models were developed: a pre-computed tomography (CT) scan situation for triaging high-risk individuals prior to imaging, and a post-CT scan situation to assist with nodule management and follow-up.
RESULTS: Four VOCs (VOC37, VOC46, VOC58 and VOC128) were identified as key compounds, showing strong diagnostic performance (area under the curve 0.900 for pre-CT scan and 0.897 for post-CT scan).
CONCLUSIONS: Our findings suggest that breath analysis could improve nodule management by refining patient selection for CT screening and reducing unnecessary invasive procedures or follow-up scans. Further validation through larger multicentre studies is needed to confirm these results.